PRVB Overview
Upcoming Projects (PRVB)
-
Don’t see a project related to the company you care about? Create your own!
Executed Projects (PRVB)
-
A Second View - Prescriber Check In: The use of Provention Bio's Templizumab (Tzield) in delaying the onset of stage 3 type 1 diabetes in patients with stage 2 type 1 diabetes.
Tickers: PRVB, VRTX
Executed On: Sep 07, 2023 at 11:00 AM EDT -
Prescriber Check In: The use of Provention Bio's Templizumab (Tzield) in delaying the onset of stage 3 type 1 diabetes in patients with stage 2 type 1 diabetes.
Tickers: PRVB, VRTX
Executed On: Sep 06, 2023 at 05:30 PM EDT -
A second look: Examining Provention Bio's Teplizumab as a new treatment to delay onset of clinical Type 1 Diabetes Mellitus
Tickers: PRVB, VRTX
Executed On: Aug 29, 2022 at 11:30 AM EDT -
Examining Provention Bio's Teplizumab as a new treatment to delay onset of clinical Type 1 Diabetes Mellitus
Ticker: PRVB
Executed On: Aug 05, 2022 at 03:00 PM EDT
Upcoming & Overdue Catalysts (PRVB)
-
Don’t see a catalyst related to the company you care about? Create your own!
Strategic Initiatives (PRVB)
-
Don’t see a strategic initiative related to the company you care about? Create your own!
